Neuronavigation for transcranial magnetic stimulation (TMS): Where we are and where we are going, Cortex, 2010
An evaluation of the role of neuronavigation in TMS treatment.
Low intensity repetitive magnetic stimulation reduces expression of genes related to inflammation and calcium signalling in cultured mouse cortical astrocytes, 2021
Research demonstrating the ability of 1Hz and 10Hz LI-rMS to modulate specific aspects of astrocytic phenotype, potentially contributing to the known effects of low intensity rTMS on excitability and neuroplasticity.
Poster presentation identifying effects of TMS in Alzheimer Disease, Neurotrophic and Antioxidant Effect of rTMS in Alzheimer’s Disease, FENS Forum 2021
Transcranial Magnetic Stimulation to Address Mild Cognitive Impairment in the Elderly: A Randomized Controlled Study, 2015
From the study: “Even though some older adults perform as well as young adults , memory processing declines with senescence, particularly in episodic memory tasks, which involve encoding and retrieval of information.
Such cognitive deficits, even mild, cause great distress to the elderly with MCI, who feel that their autonomy, independence, and ability to lead high-quality lives are negatively affected. These impairments are often considered the most debilitating aspect of aging
Transcranial magnetic stimulation (TMS) emerges as a therapeutic tool with clinical benefits in neurological and psychiatric diseases. The method is based on generating a rapidly variable magnetic field over the scalp in awake subjects, which induces a transitory electric current in the cortical surface and modulating neuronal function directly underneath the coil, and in connected brain regions.”
rTMS modulates precuneus-hippocampal subregion circuit in patients with subjective cognitive decline, 2021
TMS targeting the hippocampus to improve subjective cognitive decline.